Integrated analysis of genomic and epigenomic alterations in circulating tumor DNA in patients with colorectal cancer and advanced adenoma

ABSTRACT: Primary outcome(s): Positive rate of LUNAR assay in advanced colorectal adenoma and stage 0-2 colorectal cancer.

DISEASE(S): Colorectal Cancer And Advanced Adenoma

PROVIDER: 2652669 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR